EBV Infection in Epithelial Malignancies Induces Resistance to Antitumor Natural Killer Cells via F3-Mediated Platelet Aggregation
- PMID: 35064016
- DOI: 10.1158/0008-5472.CAN-21-2292
EBV Infection in Epithelial Malignancies Induces Resistance to Antitumor Natural Killer Cells via F3-Mediated Platelet Aggregation
Abstract
Nasopharyngeal carcinoma (NPC) and Epstein-Barr virus (EBV)-associated gastric carcinoma (EBVaGC) are two major EBV-associated epithelial malignancies, both of which are characterized by the infiltration of a large number of lymphocytes, including natural killer (NK) cells. Although NK cells can prevent the development of EBV-associated epithelial malignancies, EBV-infected tumor cells often develop resistance to surveillance by NK cells. Elucidating the interactions between NK cells and EBV-infected tumor cells will facilitate the development of more effective NK-mediated therapies for treating EBV-associated malignancies. Here we investigated the cytotoxic function of NK cells in EBV-associated epithelial malignancies and discovered that EBV infection-induced upregulation of F3 expression correlates with NK-cell dysfunction in NPC and EBVaGC. The subsequent inhibitory effect of F3-mediated platelet aggregation on NK-cell function was verified in vitro and in vivo. Mechanistically, EBV latent membrane protein 2A (LMP2A) mediated upregulation of F3 through the PI3K/AKT signaling pathway. In an NPC xenograft mouse model, inhibition of F3 restored the antitumor function of NK cells and showed therapeutic efficacy when administered with NK-cell transfer. On the basis of these findings, EBV infection induces F3-mediated platelet aggregation that inhibits the antitumor function of NK cells, providing a rationale for developing and combining NK-cell-based therapies with F3 inhibitors to treat EBV-associated epithelial malignancies.
Significance: This study reveals a mechanism by which EBV-associated epithelial malignancies escape NK-cell-mediated immune surveillance, providing a new target for improving NK-cell immunotherapy.
©2022 American Association for Cancer Research.
Similar articles
-
EBV-Upregulated B7-H3 Inhibits NK cell-Mediated Antitumor Function and Contributes to Nasopharyngeal Carcinoma Progression.Cancer Immunol Res. 2023 Jun 2;11(6):830-846. doi: 10.1158/2326-6066.CIR-22-0374. Cancer Immunol Res. 2023. PMID: 36996321
-
The Role of NK Cells in EBV Infection and EBV-Associated NPC.Viruses. 2021 Feb 15;13(2):300. doi: 10.3390/v13020300. Viruses. 2021. PMID: 33671917 Free PMC article. Review.
-
Regulation of DNA Damage Signaling and Cell Death Responses by Epstein-Barr Virus Latent Membrane Protein 1 (LMP1) and LMP2A in Nasopharyngeal Carcinoma Cells.J Virol. 2015 Aug;89(15):7612-24. doi: 10.1128/JVI.00958-15. Epub 2015 May 13. J Virol. 2015. PMID: 25972552 Free PMC article.
-
Comprehensive single-cell transcriptomic and proteomic analysis reveals NK cell exhaustion and unique tumor cell evolutionary trajectory in non-keratinizing nasopharyngeal carcinoma.J Transl Med. 2023 Apr 25;21(1):278. doi: 10.1186/s12967-023-04112-8. J Transl Med. 2023. PMID: 37098551 Free PMC article.
-
The signaling pathways of Epstein-Barr virus-encoded latent membrane protein 2A (LMP2A) in latency and cancer.Cell Mol Biol Lett. 2009;14(2):222-47. doi: 10.2478/s11658-008-0045-2. Epub 2008 Dec 13. Cell Mol Biol Lett. 2009. PMID: 19082921 Free PMC article. Review.
Cited by
-
RIG-I is an intracellular checkpoint that limits CD8+ T-cell antitumour immunity.EMBO Mol Med. 2024 Sep 25. doi: 10.1038/s44321-024-00136-9. Online ahead of print. EMBO Mol Med. 2024. PMID: 39322862
-
EBV-associated epithelial cancers cells promote vasculogenic mimicry formation via a secretory cross-talk with the immune microenvironment.Theranostics. 2024 Aug 19;14(13):5123-5140. doi: 10.7150/thno.100171. eCollection 2024. Theranostics. 2024. PMID: 39267775 Free PMC article.
-
Epstein-Barr virus: the mastermind of immune chaos.Front Immunol. 2024 Feb 7;15:1297994. doi: 10.3389/fimmu.2024.1297994. eCollection 2024. Front Immunol. 2024. PMID: 38384471 Free PMC article. Review.
-
Update on Radiotherapy Changes of Nasopharyngeal Carcinoma Tumor Microenvironment.World J Oncol. 2023 Oct;14(5):350-357. doi: 10.14740/wjon1645. Epub 2023 Sep 20. World J Oncol. 2023. PMID: 37869238 Free PMC article. Review.
-
Role of the gut microbiota in anticancer therapy: from molecular mechanisms to clinical applications.Signal Transduct Target Ther. 2023 May 13;8(1):201. doi: 10.1038/s41392-023-01406-7. Signal Transduct Target Ther. 2023. PMID: 37179402 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous